Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Loveday

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|June 15, 2000
Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapyC A Sabin, T T Yee, H Devereux, et al.
Nature|May 18, 1995
HIV results in the frame. Results confirmedM A Nowak, S Bonhoeffer, C Loveday, et al.
HIV Clinical Trials|October 9, 2001
Adherence to antiretroviral therapy: appropriate use of self-reporting in clinical practiceR J Pratt, N Robinson, H P Loveday, et al.
Journal of Medical Virology|November 20, 1997
HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical managementA N Phillips, A McLean, M A Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2005
A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigatorsD T Dunn, H Green, C Loveday, et al.
JAMA|July 10, 1996
Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working GroupC Katlama, D Ingrand, C Loveday, et al.
Annals of Neurology|February 1, 1994
Long-latency event-related potentials in asymptomatic human immunodeficiency virus type 1 infectionS Connolly, H Manji, R H McAllister, et al.
Sexually Transmitted Infections|June 20, 1998
Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverageR J Gilson, A de Ruiter, J Waite, et al.
BMJ (Clinical Research Ed.)|June 1, 1991
Hepatitis C virus: evidence for sexual transmissionR S Tedder, R J Gilson, M Briggs, et al.
Journal of Medical Virology|December 1, 1995
Use of polymerase chain reaction and quantitative antibody tests in children born to human immunodeficiency virus-1-infected mothersM L Newell, C Loveday, D Dunn, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|June 15, 2000
Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapyC A Sabin, T T Yee, H Devereux, et al.
Nature|May 18, 1995
HIV results in the frame. Results confirmedM A Nowak, S Bonhoeffer, C Loveday, et al.
HIV Clinical Trials|October 9, 2001
Adherence to antiretroviral therapy: appropriate use of self-reporting in clinical practiceR J Pratt, N Robinson, H P Loveday, et al.
Journal of Medical Virology|November 20, 1997
HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical managementA N Phillips, A McLean, M A Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2005
A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance: evaluation of resistance assays (ERA) trial investigatorsD T Dunn, H Green, C Loveday, et al.
JAMA|July 10, 1996
Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working GroupC Katlama, D Ingrand, C Loveday, et al.
Annals of Neurology|February 1, 1994
Long-latency event-related potentials in asymptomatic human immunodeficiency virus type 1 infectionS Connolly, H Manji, R H McAllister, et al.
Sexually Transmitted Infections|June 20, 1998
Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverageR J Gilson, A de Ruiter, J Waite, et al.
BMJ (Clinical Research Ed.)|June 1, 1991
Hepatitis C virus: evidence for sexual transmissionR S Tedder, R J Gilson, M Briggs, et al.
Journal of Medical Virology|December 1, 1995
Use of polymerase chain reaction and quantitative antibody tests in children born to human immunodeficiency virus-1-infected mothersM L Newell, C Loveday, D Dunn, et al.
Pageof 11